What are Arcutis Biotherapeutics, Inc.'s profit margins?

Arcutis Biotherapeutics, Inc. (ARQT) runs a 90.9% gross margin and a -12.0% operating margin, with a -13.9% net margin.

Where do Arcutis Biotherapeutics, Inc.'s ratios come from?

Every ratio is computed from Arcutis Biotherapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Arcutis Biotherapeutics, Inc. ARQT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	90.9%+2.5pp	90.2%0.0pp	90%+0.4pp	89.1%-3.2pp	88.4%-4.6pp
Efficiency
Asset turnover	1×+0.5×	1×+0.4×	0.8×+0.4×	0.7×+0.3×	0.5×+0.3×
Inventory turnover	1.4×-0.3×	2×+0.6×	1.8×+0.7×	1.9×+1.1×	1.7×+1.0×
Liquidity
Current ratio	2.7×-0.9×	3.2×-1.0×	3.5×+1.0×	3.2×-5.3×	3.6×-6.3×
Quick ratio	2.5×-0.9×	3×-1.0×	3.3×+0.9×	3×-5.1×	3.4×-6.2×
Cash ratio	0.2×-0.4×	0.3×-0.6×	0.5×-0.3×	0.7×-1.0×	0.6×-3.4×
Leverage
Debt-to-equity	0.6×-0.2×	0.6×-0.1×	0.7×-0.6×	0.8×-0.3×	0.8×-0.1×
Debt-to-assets	0.2×-0.1×	0.3×-0.1×	0.3×-0.2×	0.3×-0.2×	0.3×-0.1×
Per Share
Book value per share	$1.47+29.5%	$1.49+14.3%	$1.19-5.6%	$1.09-27.5%	$1.13-44.1%
Valuation
Market capitalization	$2.92B+57.5%	$3.56B+118%	$2.26B+108%	$1.71B+58.7%	$1.86B+62.9%
Enterprise value	$3B+57.0%	$3.63B+117%	$2.33B+101%	$1.75B+45.5%	$1.91B+65.5%
Price / sales	7×-1.7×	9.5×+1.2×	7.1×-0.7×	6.5×-1.7×	8.7×-2.0×
Price / book	15.4×+2.4×	18.8×+8.4×	14.3×+7.4×	12.3×+6.5×	13×+7.9×
EV / sales	7.2×-1.8×	9.6×+1.2×	7.3×-1.0×	6.6×-2.5×	9×-1.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Arcutis Biotherapeutics, Inc.'s profit margins?: Arcutis Biotherapeutics, Inc. (ARQT) runs a 90.9% gross margin and a -12.0% operating margin, with a -13.9% net margin.
Where do Arcutis Biotherapeutics, Inc.'s ratios come from?: Every ratio is computed from Arcutis Biotherapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.